342
Views
13
CrossRef citations to date
0
Altmetric
Articles

Comparing the effects of Calendula officinalis and clotrimazole on vaginal Candidiasis: A randomized controlled trial

, MSc, , PhD ORCID Icon, , MSc, , PhD & , PhD
Pages 1145-1160 | Received 12 Dec 2015, Accepted 01 Oct 2016, Published online: 21 Dec 2016

References

  • Aballéa, S., F. Guelfucci, J. Wagner, A. Khemiri, J. P. Dietz, J. Sobel, and M. Toumi. 2013. Subjective health status and health-related quality of life among women with recurrent vulvovaginal Candidosis (RVVC) in Europe and the USA. Health and Quality of Life Outcomes 11 (1):169. doi:10.1186/1477-7525-11-169.
  • Atai, Z., M. Ansari, A. Mousavi, and A. Mirzaei. 2007. In-vitro study of antifungal effects of selected herbal extracts on standard and wild strains of Candida albicans. Journal of Islamic Dental Association of Iran 19 (2):91–97.
  • Badiee, P., and A. Alborzi. 2011. Susceptibility of clinical Candida species isolates to antifungal agents by E-test, southern Iran: A five year study. Iranian Journal of Microbiology 3 (4):183.
  • Centers for Disease Control and Prevention, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. 2015. Sexually transmitted diseases treatment guidelines: Vulvovaginal Candidiasis. http://www.cdc.gov/std/tg2015/candidiasis.htm ( accessed June 4, 2015).
  • Crowley, P., and H. Gallagher. 2014. Clotrimazole as a pharmaceutical: Past, present and future. Journal of Applied Microbiology 117 (3):611–17. doi:10.1111/jam.2014.117.issue-3.
  • De Bernardis, F., H. Liu, R. O’Mahony, R. La Valle, S. Bartollino, S. Sandini, S. Grant, et al. 2007. Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis. The Journal of Infectious Diseases 195 (1):149–57. doi:10.1086/jid.2007.195.issue-1.
  • Efstratiou, E., A. I. Hussain, P. S. Nigam, J. E. Moore, M. A. Ayub, and J. R. Rao. 2012. Antimicrobial activity of Calendula officinalis petal extracts against fungi, as well as Gram-negative and Gram-positive clinical pathogens. Complementary Therapies in Clinical Practice 18:173–76. doi:10.1016/j.ctcp.2012.02.003.
  • Esmaili, R., A. Khalilian, E. Nasiri, H. Jafari, O. Dehghani, and S. Alipour. 2008. Study regarding the effect of Calendula officinalis cream in healing of pressure sores. Journal of Mazandaran University of Medical Sciences 18 (66):19–25.
  • Gandhi, T. N., M. G. Patel, and M. R. Jain. 2015. Prospective study of vaginal discharge and prevalence of vulvovaginal candidiasis in a tertiary care hospital. International Journal of Current Research and Review 7 (1):34–38.
  • Gazim, Z., C. Rezende, S. Fraga, T. I. Svidzinski, and D. A. Cortez. 2008. Antifungal activity of essential oil from Calendula officinalis L. (Asteraceae) growing in Brazil. Brazilian Journal of Microbiology 39:61–63. doi:10.1590/S1517-83822008000100015.
  • Giraldo, P. C., N. C. Polpeta, C. R. T. Juliato, L. P. Yoshida, R. L. G. D. Amaral, and J. E. Junior. 2012. Evaluation of sexual function in Brazilian women with recurrent vulvovaginal candidiasis and localized provoked vulvodynia. The Journal of Sexual Medicine 9 (3):805–11. doi:10.1111/j.1743-6109.2011.02584.x.
  • Hastings-Tolsma, M., and M. Terada. 2009. Complementary medicine use by nurse midwives in the U.S. Complement. Complementary Therapies in Clinical Practice 15 (4):212–19. doi:10.1016/j.ctcp.2009.06.016.
  • Hong, E., S. Dixit, P. L. Fidel, J. Bradford, and G. Fischer. 2014. Vulvovaginal candidiasis as a chronic disease: Diagnostic criteria and definition. Journal of Lower Genital Tract Disease 18 (1):31–38. doi:10.1097/LGT.0b013e318287aced.
  • Ilkit, M., and A. B. Guzel. 2011. The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: A mycological perspective. Critical Reviews in Microbiology 37 (3):250–61. doi:10.3109/1040841X.2011.576332.
  • Jahdie, F., F. Eghdampour, M. Kheyrkhah, and H. Haggani. 2011. The effect of Calendula ointment in pain intensity of episiotomy among primiparous women. Journal of Urmia Nursing and Midwifery Faculty 9:323.
  • Kangongo, M., W. Wanyoike, G. Revathi, J. Wakibia, and C. Bii. 2012. Emerging azole resistance among Candida albicans from clinical sources in Nairobi, Kenya. Journal of Agriculture, Science and Technology 13 (2):109–15.
  • Mathur, R., and M. Goyal. 2011. Antimicrobial and phytochemical estimation of Calendula officinalis against human pathogenic micro organisms. International Journal of Innovations in Biosciences 1:1–10.
  • Miceli, M. H., J. A. Díaz, and S. A. Lee. 2011. Emerging opportunistic yeast infections. The Lancet Infectious Diseases 11 (2):142–51. doi:10.1016/S1473-3099(10)70218-8.
  • Mikamo, H., K. Izumi, K. Ito, and T. Tamaya. 1995. Comparative study of the effectiveness of oral Fluconazole and intravaginal Clotrimazole in the treatment of vaginal candidiasis. Infectious Diseases in Obstetetrics and Gynecology 3 (1):7–11. doi:10.1155/S1064744995000238.
  • Mohammadi, K. H., M. Heydari, and S. Faghihzadeh. 2008. The female sexual function index (FSFI): Validation of the Iranian version. Payesh 7 (3):269–78 (in Persian).
  • Mosby. 2002. Mosby’s drug consult. London, UK: Mosby.
  • Muley, B., S. Khadabadi, and N. Banarase. 2009. Phytochemical constituents and pharmacological activities of Calendula officinalis Linn (Asteraceae): A review. Tropical Journal of Pharmaceutical Research 8 (5):455–65. doi:10.4314/tjpr.v8i5.48090.
  • Nyirjesy, P., C. Peyton, M. V. Weitz, L. Mathew, and J. F. Culhane. 2006. Causes of chronic vaginitis: Analysis of a prospective database of affected women. Obstetrics & Gynecology 108 (5):1185–91. doi:10.1097/01.AOG.0000239103.67452.1a.
  • Porsbring, T., H. Blanck, H. Tjellström, and T. Backhaus. 2009. Toxicity of the pharmaceutical Clotrimazole to marine Microalgal communities. Aquatic Toxicology 91 (3):203–11. doi:10.1016/j.aquatox.2008.11.003.
  • Preethi, K. C., G. Kuttan, and R. Kuttan. 2009. Anti-inflammatory activity of flower extract of Calendula officinalis Linn. and its possible mechanism of action. Indian Journal of Experimental Biology 47:113–20.
  • Richter, S. S., R. P. Galask, S. A. Messer, R. J. Hollis, D. J. Diekema, and M. A. Pfaller. 2005. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. Journal of Clinical Microbiology 43 (5):2155–62. doi:10.1128/JCM.43.5.2155-2162.2005.
  • Rosen, C., J. Brown, S. Heiman, C. Leiblum, R. Meston, D. Shabsigh, R. Ferguson, and R. D’Agostino. 2000. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. Journal of Sex & Marital Therapy 26 (2):191–208. doi:10.1080/009262300278597.
  • Sangamithra, V., R. Verma, S. Sengottuvelu, and R. Sumathi. 2013. Candida infections of the genitourinary tract. Research Journal of Pharmacy and Technology 6 (10):1111–15.
  • Shafaie, F. S., and A. Namazi. 2014. Prevalence, risk factors, and clinical findings of candidiasis and trichomoniasis in women supported by selected health centers of Tabriz, Iran. Crescent Journal of Medical and Biological Sciences 1 (4):130–35.
  • Szakiel, A., D. Ruszkowski, and W. Janiszowska. 2005. Saponins in Calendula officinalis L.—Structure, biosynthesis, transport and biological activity. Phytochemistry Reviews 4 (2–3):151–58. doi:10.1007/s11101-005-4053-9.
  • Van Kessel, K., N. Assefi, J. Marrazzo, and L. Eckert. 2003. Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: A systematic review. Obstetrical & Gynecological Survey 58 (5):351–58. doi:10.1097/01.OGX.0000068791.04785.8D.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.